Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2013 May;70(10):1763-78.
doi: 10.1007/s00018-013-1283-7. Epub 2013 Mar 12.

VEGF ligands and receptors: implications in neurodevelopment and neurodegeneration

Affiliations
Review

VEGF ligands and receptors: implications in neurodevelopment and neurodegeneration

Peter Carmeliet et al. Cell Mol Life Sci. 2013 May.

Erratum in

  • Cell Mol Life Sci. 2013 Jun;70(12):2221. Carmen, Ruiz de Almodovar [corrected to Ruiz de Almodovar, Carmen]

Abstract

Intensive research in the last decade shows that the prototypic angiogenic factor vascular endothelial growth factor (VEGF) can have direct effects in neurons and modulate processes such as neuronal migration, axon outgrowth, axon guidance and neuronal survival. Depending on the neuronal cell type and the process, VEGF seems to exert these effects by signaling via different receptors. It is also becoming clear that other VEGF ligands such as VEGF-B, -C and -D can act in various neuronal cell types as well. Moreover, apart from playing a role in physiological conditions, VEGF and VEGF-B have been related to different neurological disorders. We give an update on how VEGF controls different processes during neurodevelopment as well as on its role in several neurodegenerative disorders. We also discuss recent findings demonstrating that other VEGF ligands influence processes such as neurogenesis and dendrite arborization and participate in neurodegeneration.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
VEGF regulates neuronal migration. a VEGF controls migration of FBM neurons in the hindbrain. VEGF164 binds to NRP1 expressed in the FBM soma and controls their migration in the soma from rhombomere 4 (r4) to rhombomere 6 (r6). Axon guidance of these neurons is not controlled by VEGF164 but instead by semaphorin3A and semaphorin3F (SemaA/3F) which signal to receptor complexes formed by NRP1/PlxnA4 or NRP2/PlxnA3, respectively (adapted from Schwarz et al. [27]). b VEGF controls cerebellar granule cell migration during development. VEGF is expressed in Purkinje cells and controls granule cell migration from the external granule cell layer (EGL) towards the internal granule cell layer (IGL). Granule cells express VEGFR-2. VEGFR-2 forms a complex with NMDARs (NR1/NR2B) and VEGF signaling via VEGFR-2 induces the formation of VEGFR-2/NR1/NR2B receptor complexes and potentiates NMDAR-mediated currents and Ca2+ influx to control granule cell migration
Fig. 2
Fig. 2
VEGF regulates axon growth and guidance. a VEGFR-2 regulates axon outgrowth of subicular neurons. Subicular neurons extend their axons (red) from the subiculum through the postcommissural fornix tract (pf). Sema3E is expressed in the CA1 and CA3 fields of the hippocampus (blue). Subicular neurons express VEGR-2. In these neurons, VEGFR-2 forms a multiprotein complex with NRP1 and PlexinD1 and becomes activated in a Sema3E-dependent/VEGF-independent manner. Activation of VEGFR-2 leads to activation of PI3K/Akt and axon growth. b VEGF regulates commissural axon guidance at the spinal cord midline. During spinal cord development VEGF is expressed in the floor plate (green). Commissural neurons and their axons projecting towards the ventral midline express VEGFR-2 (red). Floor plate-derived VEGF signals to VEGFR-2 in commissural axons, activates SFKs at the growth cone and induces growth cone turning, thus controlling axon guidance. c VEGF controls retinal ganglion cell (RGC) axon growth and guidance at the optic chiasm. VEGF is expressed at the optic chiasm (green). Certain RGC axons express NRP1 (red). VEGF binds to NRP1 and guides the axons across the midline to project in the contralateral side. NRP1 RGC axons do not sense VEGF and are not attracted to the midline, and instead project ipsilaterally (blue)
Fig. 3
Fig. 3
VEGF in neurodegenerative diseases. a Under normal conditions, HIF-1 is complexed with CBP/p300, binds to the HRE in the VEGF promoter and drives VEGF expression. b In VEGF∂/∂ mice, the HRE is mutated and as a consequence there is a reduced expression of VEGF leading to motor neuron cell death and ALS. c In mutant SOD1G93A mice, SOD1G93A destabilizes VEGF mRNA leading to less VEGF protein expression. d −22578C/A single nucleotide polymorphism. −2578A haplotype leads to reduced expression levels of VEGF and increases the risk of sporadic ALS in humans. e VEGF coaggregates with Aβ and is slowly released from the aggregates leading to reduced levels of available VEGF and neuronal and vascular dysfunction. f PolyQ-ATXN1 represses VEGF transcription leading to reduced levels of VEGF in the cerebellum and development of spinocerebellar ataxia type 1 (SCA1)
Fig. 4
Fig. 4
VEGF in the nervous system. a VEGF exerts its effects in many different cell types in the nervous system. b VEGF has a pleiotropic role in the nervous systems and plays a role in the indicated processes (NEJ neuroeffector junction, NMJ neuromuscular junction)

References

    1. Koch S, Tugues S, Li X, Gualandi L, Claesson-Welsh L. Signal transduction by vascular endothelial growth factor receptors. Biochem J. 2011;437(2):169–183. doi: 10.1042/BJ20110301. - DOI - PubMed
    1. Holmes DI, Zachary I. The vascular endothelial growth factor (VEGF) family: angiogenic factors in health and disease. Genome Biol. 2005;6(2):209. doi: 10.1186/gb-2005-6-2-209. - DOI - PMC - PubMed
    1. Ruiz de Almodovar C, Lambrechts D, Mazzone M, Carmeliet P. Role and therapeutic potential of VEGF in the nervous system. Physiol Rev. 2009;89(2):607–648. doi: 10.1152/physrev.00031.2008. - DOI - PubMed
    1. Mackenzie F, Ruhrberg C. Diverse roles for VEGF-A in the nervous system. Development. 2012;139(8):1371–1380. doi: 10.1242/dev.072348. - DOI - PubMed
    1. Rosenstein JM, Krum JM, Ruhrberg C. VEGF in the nervous system. Organogenesis. 2010;6(2):107–114. doi: 10.4161/org.6.2.11687. - DOI - PMC - PubMed

Publication types

MeSH terms

Substances